Live feed
Filing
SC 13D/A
SC 13D/A0001104659-22-036569·Bios Equity Partners, LP
Schedule 13D ownership disclosure
LANTERN PHARMA INC
Security class unavailable · CUSIP: 51654W101
Event date: 2022-03-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.2000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-22-036569
- Form type
- SC 13D/A
- Filer
- Bios Equity Partners, LP
- CIK
- CIK 1813314
- Filed
- Mar 22, 2022
- Reporting period
- Mar 17, 2022
- Description
- Schedule 13D beneficial ownership